0008-1030 : Rapamune 1 mg/ml Oral Solution


NDC: 0008-1030
Labeler: Wyeth Pharmaceuticals Company, a Subsidiary of Pfizer Inc.
Product Type: Human Prescription Drug
Drug Name:  Rapamune
Dosage Form: Oral Solution
Application #: NDA021083
Rev. Date: 


NDC Package Codes:

  • 0008-1030-06: 1 CARTON IN 1 KIT (0008‑1030‑06) > 1 BOTTLE, GLASS IN 1 CARTON (0008‑1030‑04) > 60 ML IN 1 BOTTLE, GLASS

Active Ingredients:

  • Sirolimus

Dosage Strength:

  • 1 mg/mL

Pharmaceutical Classes:

  • Decreased Immunologic Activity [PE]
  • mTOR Inhibitor Immunosuppressant [EPC]
  • mTOR Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0008-1040 Rapamune 0.5 mg Oral Tablet by Wyeth Pharmaceuticals Company, a Subsidiary of Pfizer Inc.
  • 0008-1041 Rapamune 1 mg Oral Tablet by Wyeth Pharmaceuticals Company, a Subsidiary of Pfizer Inc.
  • 0008-1042 Rapamune 2 mg Oral Tablet by Wyeth Pharmaceuticals Company, a Subsidiary of Pfizer Inc.
  • 55154-4227 Rapamune 1 mg Oral Tablet by Cardinal Health

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0008-1030 QR Code

< Prev: 0008-0941Next: 0008-1040 >

Related Discussions:

sirolimus and eye sight
How does sirolimus effect your eyesight...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.